{"altmetric_id":4685342,"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["NewLink Genetics Corporation","Genentech, Inc."],"first_seen_on":"2015-10-28T11:43:13+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1455629418,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02048709?term=IDO&rank=11","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02048709","http:\/\/clinicaltrials.gov\/show\/NCT02048709","https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02048709?term=GDC-0919&rank=2"],"nct_id":"NCT02048709","pubdate":"2014-01-10T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"IDO Inhibitor Study for Advanced Solid Tumors","type":"clinical_trial_study_record"},"altmetric_score":{"score":12.45,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12.45},"context_for_score":{"all":{"total_number_of_other_articles":7200541,"mean":6.3358503237224,"rank":543284,"this_scored_higher_than_pct":92,"this_scored_higher_than":6656300,"rank_type":"exact","sample_size":7200541,"percentile":92},"similar_age_3m":{"total_number_of_other_articles":238236,"mean":9.5132646084748,"rank":27017,"this_scored_higher_than_pct":88,"this_scored_higher_than":211149,"rank_type":"exact","sample_size":238236,"percentile":88},"this_journal":{"total_number_of_other_articles":18543,"mean":9.5585192535864,"rank":1694,"this_scored_higher_than_pct":90,"this_scored_higher_than":16848,"rank_type":"exact","sample_size":18543,"percentile":90},"similar_age_this_journal_3m":{"total_number_of_other_articles":933,"mean":13.812137339056,"rank":96,"this_scored_higher_than_pct":89,"this_scored_higher_than":836,"rank_type":"exact","sample_size":933,"percentile":89}}},"demographics":{"poster_types":{"member_of_the_public":3,"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1,"Members of the public":3}}},"geo":{"twitter":{"US":1,"GB":1},"weibo":{"CN":1}}},"counts":{"total":{"posts_count":7},"news":{"unique_users_count":1,"unique_users":["seeking_alpha"],"posts_count":1},"twitter":{"unique_users_count":4,"unique_users":["lisamjarvis","srqstockpicker","Datamonitor_CW","DM_Oncology"],"posts_count":4},"weibo":{"unique_users_count":1,"unique_users":["\u79cb\u67ab\u66ae\u971e\u60cb\u9752\u66f2"],"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["100000981967589"],"posts_count":1}},"posts":{"weibo":[{"url":"http:\/\/weibo.com\/2111021604\/C7CEE7mQu","license":"public","citation_ids":[4685342],"posted_on":"2015-03-09T11:33:21+00:00","summary":"\u56de\u590d@\u4e3e\u5251\u5fc3\u832b\u7136:1\u671f\u8981\u5230\u4eca\u5e744\u6708\u4efdhttp:\/\/t.cn\/RZBfuni","author":{"name":"\u79cb\u67ab\u66ae\u971e\u60cb\u9752\u66f2","image":"http:\/\/tp1.sinaimg.cn\/2111021604\/50\/5715819893\/1","description":"\u751f\u7269\u533b\u836f","id_on_source":"2111021604","geo":{"lt":"22.5462321","ln":"114.0570068","country":"CN"},"followers":524}}],"twitter":[{"url":"http:\/\/twitter.com\/lisamjarvis\/statuses\/642105273092542464","license":"gnip","citation_ids":[4685342],"posted_on":"2015-09-10T22:40:01+00:00","author":{"name":"Lisa Jarvis","url":"http:\/\/cen.acs.org\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/710329372595490816\/wg7Y6pcB_normal.jpg","description":"#biotech\/#pharma reporter for @cenmag. bit 'o #science, bit 'o business. interests: drug discovery, #rarediseases, R&D, #diversityinSTEM, pharma-academe collabo","id_on_source":"lisamjarvis","tweeter_id":"84347917","geo":{"lt":41.85003,"ln":-87.65005,"country":"US"},"followers":8372},"tweet_id":"642105273092542464"},{"url":"http:\/\/twitter.com\/srqstockpicker\/statuses\/642105782054559745","license":"gnip","rt":["lisamjarvis"],"citation_ids":[4685342],"posted_on":"2015-09-10T22:42:02+00:00","author":{"name":"Boaty McBoatface","image":"https:\/\/pbs.twimg.com\/profile_images\/868242463550578690\/yRtitSWr_normal.jpg","description":"Biotech enthusiast and master googler lol  Do your own Due Diligence!  Personal posts as well.","id_on_source":"srqstockpicker","tweeter_id":"30820266","geo":{"lt":null,"ln":null},"followers":3148},"tweet_id":"642105782054559745"},{"url":"http:\/\/twitter.com\/Datamonitor_CW\/statuses\/642242219265630209","license":"gnip","rt":["lisamjarvis"],"citation_ids":[4685342],"posted_on":"2015-09-11T07:44:12+00:00","author":{"name":"Colin White","image":"https:\/\/pbs.twimg.com\/profile_images\/696703646994722816\/qMlEQqKF_normal.png","id_on_source":"Datamonitor_CW","tweeter_id":"1487715919","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":260},"tweet_id":"642242219265630209"},{"url":"http:\/\/twitter.com\/DM_Oncology\/statuses\/642242229369745408","license":"gnip","rt":["lisamjarvis"],"citation_ids":[4685342],"posted_on":"2015-09-11T07:44:14+00:00","author":{"name":"DM Oncology","url":"https:\/\/service.datamonitorhealthcare.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/2435120472\/8mhmoc7i8fwrjppmo50p_normal.png","description":"Datamonitor's in-depth analysis of the oncology market","id_on_source":"DM_Oncology","tweeter_id":"632184561","geo":{"_id":"London, UK & Boston, US"},"followers":337},"tweet_id":"642242229369745408"}],"news":[{"title":"Merck Is Improving Its Standing In A Growing Immunotherapy Subsector","url":"http:\/\/ct.moreover.com\/?a=25483657154&p=1pl&v=1&x=zLoSvpceF07hK4heLErxdQ","license":"public","citation_ids":[4685342],"posted_on":"2016-02-16T13:30:18+00:00","summary":"Back on January 12, Merck & Co. Inc. (NYSE: MRK ) announced its $400M buyout of Edinburgh, Scotland-based IOmet, a private company with an oncology focus.","author":{"name":"Seeking Alpha","url":"http:\/\/seekingalpha.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/665\/normal\/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336"}}],"facebook":[{"title":"IDO Inhibitor Study for Advanced Solid Tumors - Full Text View - ClinicalTrials.gov","url":"https:\/\/www.facebook.com\/100000981967589\/posts\/816293885080003","license":"public","citation_ids":[4685342],"posted_on":"2014-10-22T15:53:03+00:00","summary":"http:\/\/clinicaltrials.gov\/show\/NCT02048709 clinicaltrials.gov","author":{"name":"Giordano Adelgardo","url":"https:\/\/www.facebook.com\/100000981967589","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/100000981967589\/picture","id_on_source":"100000981967589"}}]}}